---
title: "Austar Lifesciences Limited (06118.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/06118.HK.md"
symbol: "06118.HK"
name: "Austar Lifesciences Limited"
industry: "Life Sciences Tools and Services"
---

# Austar Lifesciences Limited (06118.HK)

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Location | HK Market |
| Website | [www.austar.com.hk](https://www.austar.com.hk) |

## Company Profile

Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. The company operates through Integrated Process and Packaging Equipment & Systems (I...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:11.000Z

**Overall: C (0.49)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 13 / 14 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -5.28% |  |
| Net Profit YoY | 152.11% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.48 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 425.44M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 1.58B |  |


**Multi Score**: C

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 4.43% | C |
| Profit Margin | 2.41% | C |
| Gross Margin | 21.02% | D |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -5.28% | D |
| Net Profit YoY | 152.11% | A |
| Total Assets YoY | -3.31% | D |
| Net Assets YoY | 5.74% | B |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 4151.55% | A |
| OCF YoY | -5.28% | D |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.70 | B |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 60.05% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Austar Lifesciences Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "4.43%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "2.41%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "21.02%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-5.28%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "152.11%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-3.31%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "5.74%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "4151.55%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-5.28%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.70",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "60.05%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | WUXI APPTEC (HK.2359) | A | A | C | B | B | B |
| 02 | WUXI BIO (HK.2269) | B | B | D | A | B | B |
| 03 | WUXI XDC (HK.2268) | A | A | B | B | B | B |
| 04 | XTALPI (HK.2228) | D | A | E | A | C | B |
| 05 | PHARMARON (HK.3759) | B | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 11.02 | 2/15 | 23.32 | 16.47 | 12.75 |
| PB | 0.48 | 1/15 | 0.66 | 0.52 | 0.47 |
| PS (TTM) | 0.27 | 1/15 | 0.36 | 0.29 | 0.24 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/06118.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/06118.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/06118.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.